IN8bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	21.28	18.18	37.02	17.99	0.61
Cash & Cash Equivalents	21.28	18.18	37.02	17.99	0.61
Cash Growth	17.05%	-50.89%	105.74%	2849.84%	-
Other Current Assets	3.34	4.05	1.96	0.15	0.15
Total Current Assets	24.63	22.23	38.98	18.14	0.76
Property, Plant & Equipment	8.57	10.3	2.83	0.19	0.27
Long-Term Investments	0.26	0.25	0.25	0.14	0
Other Long-Term Assets	0.26	0.26	0.16	2.44	0.09
Total Long-Term Assets	9.08	10.81	3.24	2.77	0.37
Total Assets	33.71	33.04	42.22	20.91	1.13
Accounts Payable	0.92	2.09	0.4	0.62	0.56
Current Debt	1.51	1.39	0.63	0.17	0
Other Current Liabilities	2.96	2.34	1.24	1.78	0.09
Total Current Liabilities	5.39	5.82	2.26	2.57	0.65
Long-Term Debt	3.38	4.49	1.78	0	0
Other Long-Term Liabilities	0	0	0	0.02	0.83
Total Long-Term Liabilities	3.38	4.49	1.78	0.02	0.83
Total Liabilities	8.77	10.31	4.04	2.59	1.48
Total Debt	4.89	5.87	2.41	0.17	0
Debt Growth	-16.70%	143.73%	1285.06%	-	-
Retained Earnings	-91.22	-61.21	-32.69	-18.04	-9.48
Shareholders' Equity	24.94	22.73	38.18	-16.58	-9.24
Net Cash / Debt	16.39	12.31	34.61	17.82	0.61
Net Cash / Debt Growth	33.16%	-64.44%	94.23%	2821.31%	-
Net Cash Per Share	0.55	0.59	3.47	5.21	0.19
Working Capital	19.23	16.41	36.72	15.57	0.12
Book Value Per Share	0.83	1.08	3.83	-4.85	-2.90

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).